AIM Vaccine Co., Ltd. (6660.HK)

HKD 3.39

(-0.29%)

Operating Expenses Summary of AIM Vaccine Co., Ltd.

  • AIM Vaccine Co., Ltd.'s latest annual operating expenses in 2023 was 1.35 Billion CNY , down -4.05% from previous year.
  • AIM Vaccine Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 530.37 Million CNY , down -75.43% from previous quarter.
  • AIM Vaccine Co., Ltd. reported a annual operating expenses of 1.4 Billion CNY in annual operating expenses 2022, down -25.78% from previous year.
  • AIM Vaccine Co., Ltd. reported a annual operating expenses of 1.89 Billion CNY in annual operating expenses 2021, up 118.46% from previous year.
  • AIM Vaccine Co., Ltd. reported a quarterly operating expenses of 742.76 Million CNY for 2023 Q2, down -12.84% from previous quarter.
  • AIM Vaccine Co., Ltd. reported a quarterly operating expenses of 2.15 Billion CNY for 2023 Q4, up 190.58% from previous quarter.

Annual Operating Expenses Chart of AIM Vaccine Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of AIM Vaccine Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 1.35 Billion CNY -4.05%
2022 1.4 Billion CNY -25.78%
2021 1.89 Billion CNY 118.46%
2020 868.9 Million CNY 48.79%
2019 583.97 Million CNY 0.0%

Peer Operating Expenses Comparison of AIM Vaccine Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -315.849%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD -82.848%